ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000233847.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.045889341	Sensitive
ENSG00000233847.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.005321648	Sensitive